Fox Business - The Power to Prosper
Search Site

Novo Nordisk

Investing in stocks that won’t go out of style

Gabelli Funds portfolio manager Howard Ward on stocks that will consistently boost investors’ portfolios.

Read More

  1. China drug sector probe widens as Novo site visited

    Chinese authorities have visited a site operated by Danish drugmaker Novo Nordisk A/S , the world's biggest maker of insulin, the latest evidence of a widening inves...

  2. Weekly Preview: Earnings Season Nears The End, China in Focus

    Economic data and central bank meetings will dominate financial news again next week as the Bank of Japan and Reserve Bank of Australia hold their monthly policy mee...

  3. Leadership Lessons from the Paula Deen Controversy

    I told myself not to get involved in the whole Paula Deen mess. I said to myself, "It's a train wreck. She's radioactive. Let it go and just walk away."In the end, I...

  4. EUROPE MARKETS: Europe Stocks Key Off Asia Gains; Banks Rally

    European stock markets posted solid gains on Tuesday, with banks in the driver's seat, as investors took inspiration from Asia, where a weaker yen spurred a rally fo...

  5. Novo Nordisk : Liraglutide Leads to Weight Loss in Study

    Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) Thursday said treatment with its drug liraglutide led to an average 8% weight loss in patients in a 56-wee...

  6. Novo Buys Xellia Pharmaceuticals for $700 Million

    Denmark's privately-held holding company Novo A/S said Tuesday it has acquired Xellia Pharmaceuticals for $700 million from 3i Group PLC (III.LN) and other sharehold...

  7. Novo Nordisk Net Profit Up As Insulin Sales Surge

    Denmark's Novo Nordisk A/S (NOVO-B.KO), the world's largest maker of insulin, Wednesday posted a forecast-beating first-quarter net profit rise of 28%, helped by str...

  8. Mexico Hit With a Spike in Diabetes Cases

    An alarming number of Mexicans are being diagnosed with diabetes, making the country a priority market for tackling a disease that is exploding in developing countri...

  9. FDA Conducting Safety Review Of Certain Diabetes Drugs

    The U.S. Food and Drug Administration Thursday said it is reviewing information about a class of diabetes drugs that suggests they might cause pre-cancerous changes ...

  10. For Nordic bosses, joys of home trump top dollar pay

    Executive excess need not be etched in stone. Just look at the Nordic region, where an egalitarian tradition and a high quality of life leave top managers content wi...

  11. These ETFs Have Moving Average Problems

    Let's quickly clear up that headline. Not all of the ETFs that will be highlighted here have violated a key moving average such as the 50- or 200-day lines.However, ...

  12. Glaxo Research Chief Looks Ahead to Next Wave of New Medicines

    UPPER MERION, Pa.--Drug maker GlaxoSmithKline PLC (GSK, GSK.LN) is keeping regulators busy with six new drug applications under review but 2013 also is shaping up as...

  1. Novo Nordisk Upgraded to 'Buy'

    Novo Nordisk (NYSE:NVO) was handed an upgrade to "buy" from "hold" on Tuesday from Austria's Erste Group, helping to boost its shares 1%.The Denmark-based drug giant...

  2. European Stocks Eye Weekly Loss Ahead of U.S. Jobs Data

    European stock markets headed lower on Friday, with the benchmark index heading for its first weekly loss since January, as investors remained cautious ahead of nonf...

  3. European ETFs Flying Under The Radar

    The S&P 500 hit a new all-time high on Monday, and the NASDAQ is trading at the best level in 13 years.Both indices are in the midst of a strong bull market -- but t...

  4. Lilly Pumps $700M into Insulin Manufacturing

    Eli Lilly (NYSE:LLY) is increasing its annual investment in insulin production by another $700 million as it looks to help thwart the growing number of diabetes case...

  5. Time To Consider Investing In Scandinavia (EWD, EFNL, NORW, EDEN, GXF)

    The woes in Western Europe were greatly documented during the financial crisis a few years ago. The PIIGS were the countries at the greatest risk of imploding and af...

  6. Novo Nordisk Rises 1.6% After FDA Approval

    Shares of Novo Nordisk AS climbed 1.6% on Wednesday after the Danish drug maker said the U.S. Food and Drug Administration approved its Novoeight drug for use in adu...

  7. Top insulin maker Novo caught up in China's widening drug probes

    Chinese authorities have visited a site operated by Danish drugmaker Novo Nordisk A/S , the world's biggest maker of insulin, in the latest sign of a widening invest...

‹ Prev12345Next ›
Freebase CC-BY
Source: Novo Nordisk on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL